NCT02903407 - Pain, Agitation and Delirium (PAD) Protocol in the Duke CICU | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

September 1, 2017

Primary Completion Date

June 30, 2019

Study Completion Date

June 30, 2019

Conditions

Deep SedationVentilators, MechanicalCritical Illness

Interventions

DRUG

Midazolam

IV midazolam will be administered as a continuous infusion to maintain set goal sedation level of RASS 0 to -2.

DRUG

Propofol

IV propofol will be administered as a continuous infusion to maintain set goal sedation level of RASS 0 to -2.

DRUG

Dexmedetomidine

IV dexmedetomidine will be administered as a continuous infusion to maintain set goal sedation level of RASS 0 to -2.

Trial Locations (1)

Duke University Medical Center, Durham